BiotechTube
Home/Bantam Pharmaceutical/Michael Stocum, MS
MS

Michael Stocum, MS

President & CEO

Bantam Pharmaceutical

Therapeutic Areas

OncologyHematological MalignanciesSolid Tumors

Bantam Pharmaceutical Pipeline

DrugIndicationPhase
BTM-3566Mature B-cell Lymphomas (DLBCL, MCL, FL)Pre-clinical

Leadership Team at Bantam Pharmaceutical

MK
Matthew Kostura, PhD
Chief Scientific Officer
GW
Glen Weiss, MD, MBA
Chief Medical Officer
BM
Briggs Morrison, MD, PhD
Scientific Advisor
View full Bantam Pharmaceutical profile